Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP634845.RAggp4ieM35epOn16N1JudvxqgaV74VrX3HJvwTLMiGLg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP634845.RAggp4ieM35epOn16N1JudvxqgaV74VrX3HJvwTLMiGLg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP634845.RAggp4ieM35epOn16N1JudvxqgaV74VrX3HJvwTLMiGLg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP634845.RAggp4ieM35epOn16N1JudvxqgaV74VrX3HJvwTLMiGLg130_provenance.
- NP634845.RAggp4ieM35epOn16N1JudvxqgaV74VrX3HJvwTLMiGLg130_assertion description "[We conducted a case-control study on a total of 280 patients with Type 2 diabetes, comparing those without retinopathy or nephropathy (n = 92) and those with microangiopathies (n = 188), for the association of polymorphisms in four candidate genes, paraoxonase 1 (PON1), plasminogen activator inhibitor-1, fibrinogen, and platelet glycoprotein Ibalpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634845.RAggp4ieM35epOn16N1JudvxqgaV74VrX3HJvwTLMiGLg130_provenance.
- NP634845.RAggp4ieM35epOn16N1JudvxqgaV74VrX3HJvwTLMiGLg130_assertion evidence source_evidence_literature NP634845.RAggp4ieM35epOn16N1JudvxqgaV74VrX3HJvwTLMiGLg130_provenance.
- NP634845.RAggp4ieM35epOn16N1JudvxqgaV74VrX3HJvwTLMiGLg130_assertion SIO_000772 15270786 NP634845.RAggp4ieM35epOn16N1JudvxqgaV74VrX3HJvwTLMiGLg130_provenance.
- NP634845.RAggp4ieM35epOn16N1JudvxqgaV74VrX3HJvwTLMiGLg130_assertion wasDerivedFrom befree-20150227 NP634845.RAggp4ieM35epOn16N1JudvxqgaV74VrX3HJvwTLMiGLg130_provenance.
- NP634845.RAggp4ieM35epOn16N1JudvxqgaV74VrX3HJvwTLMiGLg130_assertion wasGeneratedBy ECO_0000203 NP634845.RAggp4ieM35epOn16N1JudvxqgaV74VrX3HJvwTLMiGLg130_provenance.
- befree-20150227 importedOn "2015-02-27" NP634845.RAggp4ieM35epOn16N1JudvxqgaV74VrX3HJvwTLMiGLg130_provenance.